Page 5 - போர்டேஜ் பயோடெக் இன்க் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Portage Biotech Divests Portage Pharmaceuticals Limited to Juvenescence Ltd Portage may be entitled to up to USD $244 million in future milestone payments -Toronto, Ontario– – Portage Biotech Inc. a clinical stage immuno-oncology company accelerating research and development to overcome immune resistance, today announced the divestment of its three legacy businesses; Portage Pharmaceuticals Limited including subsidiaries Portage Glasgow Ltd. and EyGen Ltd, to Juvenescence Ltd., a company … Portage may be entitled to up to USD $244 million in future milestone payments – Toronto, Ontario–(Newsfile Corp. – March 4, 2021) – Portage Biotech Inc. (NASDAQ: PRTG) (CSE: PBT.U) (“Portage” or the “Company”) a clinical stage immuno-oncology company accelerating research and development to overcome immune resistance, today announced the divestment of its three legacy businesses; Portage Pharmaceuticals Limited (PPL), including subsidiaries Portage Glasgow Ltd. and EyGen L

Jim mellonDeclan dooganGreg baileyIan waltersKate caruso sharpeChuck padalaJuvenescence ltdPortage pharmaceuticals limitedPortage biotech incNewsfile corpNeither the canadian securities exchangeEygen ltdCanadian securities exchangePortage glasgow ltdPortage biotechPortage glasgow